Latest News

Risklick joins Debiopharm Innovation Fund Portfolio

Yonalink Partners with AI4LUNGS

BC Platforms and NTT Group announce exclusive collaboration

Genialis uses machine learning to personalize cancer treatment outcomes

New Genialis RNA biomarker accurately predicts KRAS outcomes in lung cancer patients

Nucleai and GoPath Diagnostics announce strategic collaboration

SIFTED – Clinical trials need a revamp — could Europe lead the charge?

Merck’s M Ventures supports Nucleai’s spatial AI biomarker technology for clinical trial enrolment

Nucleai and Altis Labs are transforming clinical trials through AI innovation